Hypertension and cardiovascular risk in primary care (WHO HEARTS)
High blood pressure is the most common reason people die early from heart attack and stroke, and most of it can be controlled in primary care with a few cheap medicines. This course takes you through the WHO HEARTS approach: measure well, treat by protocol, think about total cardiovascular risk, and keep people on treatment as a team.
- Measure blood pressure accurately, avoid the common measurement pitfalls and confirm a diagnosis of hypertension.
- Start and step up treatment using a drug- and dose-specific protocol based on WHO first-line medicines.
- Use WHO risk charts to estimate total cardiovascular risk and act on it.
- Organise follow-up, adherence support, registers and team-based care, and know when to refer.
- Recognise hypertension in pregnancy, act on severe pre-eclampsia and adjust treatment for women who are or could become pregnant.
Why blood pressure matters, and what HEARTS is
- Describe the size of the hypertension problem and the control gap.
- Name the six modules of the WHO HEARTS technical package.
Raised blood pressure damages arteries quietly for years before it causes a stroke, heart attack, heart failure or kidney failure. Most people with it feel completely well, which is why so many are never diagnosed.
WHO estimates that about 1.4 billion adults aged 30 to 79 had hypertension in 2024, around one in three in that age group, and two thirds of them live in low- and middle-income countries. Roughly 44% do not know they have it, and only about 23% have it controlled.
Source: WHO hypertension fact sheet
The good news is that treatment is safe, cheap and effective. The problem is rarely a lack of medicines in the world; it is that health systems do not find people, start treatment, or keep them on it.
The HEARTS technical package
WHO launched the Global Hearts Initiative in 2016. Its HEARTS technical package gives primary care teams six practical modules:
| Letter | Module | In practice |
|---|---|---|
| H | Healthy-lifestyle counselling | Brief advice on tobacco, salt, diet, activity and alcohol at every visit |
| E | Evidence-based treatment protocols | One simple drug- and dose-specific protocol used by everyone |
| A | Access to essential medicines and technology | A reliable supply of a few protocol medicines and validated BP devices |
| R | Risk-based CVD management | Using total cardiovascular risk, not one number, to decide who needs most |
| T | Team-based care | Nurses, clinical officers, pharmacists and community health workers sharing tasks |
| S | Systems for monitoring | Simple registers that show how many people are treated and controlled |
The rest of this course follows the same logic: measure well (lesson 2), treat by protocol (lesson 3), think about total risk (lesson 4), keep people on treatment as a team and track the results (lesson 5), and take extra care in pregnancy and other special situations (lesson 6).
Your clinic sees 120 adults a day for all sorts of problems. Blood pressure is only measured when someone complains of headache. Last month 9 people were started on antihypertensives, each on a different combination, and the pharmacy ran out of two of them.
Which HEARTS modules would help most here?
Evidence-based treatment protocols (one standard protocol so prescriptions are predictable), Access to essential medicines (forecast and stock the few protocol medicines), and a change in practice so blood pressure is measured in every adult, not only those with headache. Monitoring would show the scale of the gap.
Why is measuring only people with headache a problem?
Hypertension is usually symptom-free, and headache is a poor guide to blood pressure. Waiting for symptoms means most people are missed until they have a stroke or heart attack.
- About one in three adults aged 30 to 79 has hypertension; fewer than one in four of them is controlled.
- Hypertension is usually silent: you have to measure to find it.
- HEARTS: Healthy lifestyle, Evidence-based protocols, Access to medicines, Risk-based management, Team-based care, Systems for monitoring.
Measuring blood pressure and making the diagnosis
- Measure blood pressure with correct technique and equipment.
- Confirm a diagnosis of hypertension and recognise when to act the same day.
- Recognise the common errors in equipment and technique that give a wrong reading, and how to avoid them.
Every treatment decision rests on the reading, so a careless measurement leads to wrong treatment. Small habits make a big difference.
Technique
- Seat the person with the back supported, legs uncrossed and bladder empty.
- Let them rest quietly for 5 minutes, and do not talk during the measurement.
- Choose the right cuff: use a large cuff if the upper arm is more than 32 cm round. A cuff that is too small reads falsely high.
- At a first assessment, measure at least twice a few minutes apart and use the second reading.
- Measuring both arms once and using the higher arm is ideal, but may not be practical in a busy clinic.
Equipment
Where the clinic has electricity or batteries, use a validated automated device with a digital display: it gives more consistent readings and does not depend on the operator's technique. Without power, use a manual cuff with a gauge and a stethoscope.
Who to measure
Measure blood pressure in every adult at their first visit to the facility and, if normal, at regular intervals afterwards (for example every 1 to 5 years). It matters most in people with previous heart attack or stroke, diabetes, chronic kidney disease, obesity, tobacco use, or a family history of heart attack or stroke.
Making the diagnosis
| First reading (mmHg) | Next step |
|---|---|
| 160/100 or higher | High enough to start treatment on the same day, without waiting for a second visit |
| 140 to 159, or 90 to 99 | Recheck on another day, usually within 1 to 4 weeks. Hypertension is diagnosed if systolic is 140 or more and/or diastolic is 90 or more on both days |
| Below 140/90 | Not hypertension. Give lifestyle advice and recheck later |
Pitfalls that lead to a wrong diagnosis
Most measurement errors push the reading up, so people are labelled and treated when they do not need it. A few push it down, so people at risk are missed. Look for these at every clinic you work in.
| Pitfall | What goes wrong | What to do |
|---|---|---|
| Cuff too small for the arm | Reads falsely high | Measure the arm; use a large cuff if it is more than 32 cm round |
| No rest, talking, legs crossed, back unsupported, full bladder | Reads higher than the true resting value | Seat, support, rest 5 minutes in silence; ask the person to empty the bladder first |
| One high reading at one visit | Over-diagnosis | Confirm on another day unless 160/100 or higher |
| Rounding to the nearest 0 or 5 with a manual device (terminal digit preference) | Wrong decisions near the 140/90 threshold | Write down the exact number; prefer a validated automated device |
| Dial (aneroid) device not checked | Loses accuracy, especially after being knocked or dropped | Check calibration at least every 6 months, and after any fall |
| Automated device not clinically validated | Some give inaccurate readings | Buy and use only devices validated by a recognised protocol |
| Irregular pulse, for example atrial fibrillation | Many automated devices are not accurate | Feel the pulse first; if irregular, repeat readings, check by another method if you can, and assess the irregular pulse |
WHO now recommends validated automated devices for clinical use. Mercury devices are no longer recommended because mercury is toxic and is being phased out, and dial devices need frequent recalibration and retraining of staff. Automated devices also remove observer bias and rounding.
Second case: the dropped device
Mr E, 70, comes for a repeat prescription. The clinic's dial device fell off the table last week and since then most readings have been 150 to 160 systolic. Today it reads 168/96. His radial pulse is irregular.
No. A dial device that has been dropped may have lost calibration, and an irregular pulse makes single readings unreliable. Have the device checked (calibration at least every 6 months and after any fall) and use a validated automated device or a checked manual device meanwhile.
2. What else does he need?
Repeat readings with a reliable device, and assessment of the irregular pulse (for example an ECG or referral, as your protocol allows), because atrial fibrillation needs its own management. Confirm his BP before changing his treatment.
Mrs A comes for a dressing on her hand. She walked fast to the clinic and is talking as the nurse takes her blood pressure with a standard cuff on a large upper arm (34 cm). The reading is 158/96.
What is wrong with this measurement?
She has not rested for 5 minutes, she is talking, and the cuff is too small for her arm (over 32 cm needs a large cuff). All three push the reading up.
After a correct repeat, her blood pressure is 152/94. What next?
This is in the 140 to 159 or 90 to 99 range, so recheck on another day, usually within 1 to 4 weeks. If it is still 140/90 or higher, the diagnosis is confirmed and treatment should start within 4 weeks of diagnosis.
- Rest 5 minutes, no talking, back supported, right cuff size; take two readings and use the second.
- Use a validated automated device where there is power.
- Confirm on a second day unless BP is 160/100 or higher, which can be treated the same day.
- Most errors raise the reading: wrong cuff, no rest, rounding, uncalibrated dial devices. Use validated automated devices; check dial devices at least every 6 months.
Treatment protocols and essential medicines
- Apply the WHO thresholds and targets for treatment.
- Start and step up treatment with first-line essential medicines, including in women who could become pregnant.
When to start
- Confirmed hypertension with systolic 140 or more, or diastolic 90 or more: start medicines (WHO strong recommendation).
- Existing cardiovascular disease and systolic 130 to 139: start medicines (strong).
- No cardiovascular disease but high cardiovascular risk, diabetes or chronic kidney disease, and systolic 130 to 139: WHO suggests starting medicines (conditional).
- Start no later than 4 weeks after diagnosis; start without delay if BP is very high (for example 160/100 or more) or there is organ damage.
Tests
If available, check electrolytes and creatinine, lipids, HbA1c or fasting glucose, a urine dipstick and an ECG. But never let tests delay treatment: in places without a laboratory, start treatment and test later. A long-acting calcium channel blocker such as amlodipine is the easiest medicine to start without tests.
Which medicines
WHO recommends any of three classes as first line: a thiazide or thiazide-like diuretic, an ACE inhibitor or ARB, or a long-acting dihydropyridine calcium channel blocker. Long-acting, once-daily medicines are preferred. WHO suggests starting with two medicines from different classes, ideally as a single-pill combination, because it improves adherence and control, especially when BP is 20/10 mmHg or more above target.
| Example medicine | Starting dose | Full dose |
|---|---|---|
| Amlodipine | 5 mg | 10 mg |
| Lisinopril | 20 mg | 40 mg |
| Losartan | 50 mg | 100 mg |
| Telmisartan | 40 mg | 80 mg |
| Chlorthalidone | 12.5 mg | 25 mg |
Stepping up
HEARTS protocols are drug- and dose-specific so that every member of the team does the same thing. A typical one: start an ACE inhibitor or ARB with amlodipine at starting doses; if BP is still 140/90 or more at the monthly visit, move to full doses; then add a thiazide-like diuretic; if still not controlled, check the tablets are being taken correctly and, if they are, refer.
Targets
- Below 140/90 for people with hypertension and no other conditions (strong).
- Systolic below 130 for people with known cardiovascular disease (strong).
- Systolic below 130 suggested for people at high cardiovascular risk, or with diabetes or chronic kidney disease (conditional).
- ACE inhibitors cause a dry cough in about 1 in 10 people: switch to an ARB.
- Check creatinine and potassium before and a few weeks after starting an ACE inhibitor, ARB or diuretic, where possible. Low potassium is more common at full diuretic doses.
- Beta-blockers are not first line, but add one after a recent heart attack, or for atrial fibrillation or heart failure.
- If someone is already controlled on an affordable regimen, there is no need to change it.
Mr B's BP was 168/102 last month and 164/100 today. He has no symptoms, no diabetes and has never had a heart attack or stroke. There is no laboratory at your health centre. Your national protocol uses amlodipine, lisinopril and hydrochlorothiazide.
Should you wait for blood tests before treating?
No. Treatment should not be delayed because tests are not available. He has confirmed hypertension at a level that needs treatment now; tests can be done later if they become available.
What would a protocol-based start look like, and what is his target?
Following the national protocol, for example amlodipine 5 mg once daily, or two first-line medicines together if that is how the protocol starts. Review in one month and step up (full dose, then add the next class) until BP is below 140/90.
- Treat confirmed BP of 140/90 or more; treat from 130 systolic with existing cardiovascular disease.
- First line: thiazide-like diuretic, ACE inhibitor or ARB, long-acting calcium channel blocker; two medicines, ideally one pill.
- Never delay treatment for tests. No ACE inhibitor, ARB or thiazide in pregnancy or in women who could become pregnant without effective contraception.
- Target below 140/90; systolic below 130 with cardiovascular disease.
Total cardiovascular risk
- Use the WHO cardiovascular risk charts to estimate 10-year risk.
- Match management and follow-up to the level of risk.
Blood pressure is one risk factor among several. A 45-year-old non-smoker with BP 145/92 and a 68-year-old smoker with diabetes and the same BP have very different chances of a heart attack or stroke. Treating according to total risk puts effort where it saves most lives.
The WHO risk charts
WHO's 2019 cardiovascular risk charts estimate the 10-year risk of a fatal or non-fatal heart attack or stroke. There are charts for 21 world regions, so choose the one for your country. The laboratory version uses age, sex, smoking, systolic BP, diabetes and total cholesterol. The non-laboratory version uses body mass index instead of blood tests, so it can be used anywhere.
| Colour | 10-year risk | Management (adapted from WHO PEN, in HEARTS) |
|---|---|---|
| Green | Under 5% | Lifestyle counselling; reassess in 12 months |
| Yellow | 5% to under 10% | Lifestyle counselling; every 3 months until targets met, then every 6 to 9 months |
| Orange | 10% to under 20% | Counselling; consider medicines if BP stays 140/90 or more; review every 3 to 6 months |
| Red and deep red | 20% or more | Counselling; consider medicines if BP stays 130/80 or more; give a statin; review every 3 months; refer if risk has not fallen after 6 months |
Treat without a chart
Some people are high risk whatever the chart says, so do not waste time scoring them: anyone with established cardiovascular disease (heart attack, angina, stroke or TIA, peripheral vascular disease) or kidney disease, people with diabetes and cardiovascular disease, people with albuminuria, retinopathy or left ventricular hypertrophy, anyone with BP persistently 160/100 or more, and anyone with total cholesterol of 8 mmol/L or more.
Statins and aspirin
- Give a statin to people at 20% or higher risk and after a heart attack or stroke; HEARTS-D also recommends a statin for everyone with type 2 diabetes aged 40 and over. Use the statin and dose in your national formulary. No statins in pregnancy.
- Low-dose aspirin is for people who have already had a heart attack or ischaemic stroke, not for prevention in people without cardiovascular disease.
- WHO counts medicines plus counselling for people with a previous heart attack or stroke, or a 10-year risk of 20% or more, among its "best buys" for noncommunicable diseases.
Ms C is 44, does not smoke, has no diabetes, and her BP is confirmed at 136/86. Mr D is 66, smokes, has diabetes, and his BP is also 136/86. You use the non-laboratory chart for your region: Ms C is green (under 5%); Mr D is red (20 to under 30%).
How would you manage Ms C?
Lifestyle counselling (salt, diet, activity, tobacco, alcohol) and reassess in 12 months. Her BP is below the threshold for treatment and her risk is low.
How would you manage Mr D?
Counselling including stopping smoking, consider BP medicines because his BP is persistently 130/80 or more at high risk (WHO also suggests treating systolic 130 to 139 in people with diabetes), give a statin, manage his diabetes, and review every 3 months.
- Total cardiovascular risk, not one number, decides how hard to treat.
- Use the WHO 2019 chart for your region; the non-laboratory chart needs no blood tests.
- 20% or higher 10-year risk: counselling, statin, lower BP threshold, 3-monthly review.
- Established cardiovascular disease counts as high risk without scoring; aspirin only for secondary prevention.
Follow-up, adherence and team-based care
- Plan follow-up visits and support people to stay on treatment.
- Share hypertension care safely across the team and track control.
- Keep a hypertension register and calculate the WHO HEARTS blood pressure control indicator.
How often to see people
- Monthly after starting or changing treatment, until BP is at target (WHO suggestion).
- Every 3 to 6 months once BP is controlled.
- Each visit: BP, side effects, tablets taken, supply at home, and one lifestyle message.
Helping people stay on treatment
- Explain what hypertension is, that it causes no symptoms, and what it can lead to: stroke, heart attack, kidney failure.
- Explain the difference between long-term medicines and quick-relief tablets such as painkillers.
- Show the dose, label the tablets, and use once-daily medicines taken at the same time each day.
- Ask the person to keep a supply at home and to come back before it runs out.
- Check understanding before they leave.
These tablets do not cure high blood pressure; they control it, like a roof keeps out the rain. If you stop them, the pressure goes back up even though you feel well.
Lifestyle messages
- Less than 5 g of salt a day (under 2 g of sodium, just under one teaspoon), counting salt already in food.
- At least 5 portions of fruit and vegetables a day; healthy oils; less added sugar.
- About 150 minutes of brisk walking or similar a week.
- Stop tobacco (smoked and smokeless) and avoid others' smoke; avoid harmful alcohol.
Team-based care
WHO suggests that hypertension treatment can be given by non-physician professionals such as nurses and pharmacists, as long as four conditions are met: proper training, prescribing authority, a specific management protocol, and physician oversight (which can be remote). Community health workers can help with education, delivering medicines and measuring and monitoring BP, within local rules.
Monitoring
A simple register (paper or electronic) of everyone on treatment is the backbone of follow-up. HEARTS asks for four items for each person: date of registration, date of last visit, and the systolic and diastolic BP at that visit. With those four items the team can see who is overdue and how many people are controlled.
| Indicator | How to count it |
|---|---|
| Blood pressure control at 6 months (HEARTS) | Take everyone registered for treatment in the quarter that ended 6 months ago (B). Count how many of them had BP below 140/90 at their last visit in the most recent quarter (A). Control rate = A divided by B |
| Missed visits | Each week or month, list people whose next visit date has passed; give the list to community health workers to follow up |
| Lost to follow-up | People with no visit for a long period (programmes often use 6 or 12 months; use your national definition) |
People who have died, moved or been lost stay in the denominator, so a low control rate often shows a retention problem, not a medicine problem. Review the figures with the whole team every quarter and agree one change to try.
We keep your name in our book so we notice if you miss a visit. If you move or cannot come, tell us and we will help you get your tablets.
Second case: a team-based clinic day
At a rural health centre, a community health worker measures BP in the village and brings people to the clinic; a nurse runs the hypertension clinic under the national protocol; the pharmacist dispenses; the doctor visits monthly. Mrs F, 60, takes amlodipine 5 mg and lisinopril 20 mg. Her BP today is 152/94 on two good readings. She says she takes her tablets every morning.
Follow the next protocol step: check side effects and adherence (pill count or ask her to show the tablets), then step up, for example to full doses (amlodipine 10 mg, lisinopril 40 mg) if that is the next step in your protocol, and review in one month.
2. What are the roles of the others?
The pharmacist dispenses the new dose, labels it and checks understanding. The community health worker checks BP and reminds her of her next visit. The doctor reviews her at the monthly visit if she is still not controlled after the full protocol, or at once if there are warning signs.
3. How will the team know whether the clinic is working?
From the register: the HEARTS control indicator each quarter, and the list of missed visits.
Your district wants nurses to run the hypertension clinic on two days a week, with the only doctor visiting once a month. Several patients have missed appointments and come back months later with very high BP.
What must be in place for nurses to start and adjust treatment safely?
Training, the legal authority to prescribe, a specific drug- and dose-specific protocol, and physician oversight (for example monthly review and a way to ask for advice remotely).
How could you reduce missed appointments?
Use a register to spot people who miss visits, give enough medicine to last until the next visit, explain why treatment continues without symptoms, involve community health workers for reminders and BP checks, and keep visits short and predictable.
- Monthly until controlled, then every 3 to 6 months.
- Adherence is built at every visit: explain, show, label, simplify, check understanding.
- Nurses and pharmacists can treat with training, prescribing authority, a protocol and physician oversight.
- A simple register showing treated and controlled patients drives improvement.
- Register four items for each person: registration date, last visit date, systolic and diastolic BP. Count the control rate every quarter.
Hypertension in pregnancy and other special situations
- Classify hypertension in pregnancy and recognise severe pre-eclampsia.
- Give first-level care and refer a woman with severe hypertension or pre-eclampsia.
- Adjust treatment for a woman with known hypertension who is planning a pregnancy, pregnant or has just given birth.
High blood pressure in pregnancy is common and dangerous. WHO estimates that hypertensive disorders complicate about one pregnancy in ten, and in Asia and Africa nearly one tenth of maternal deaths are associated with them. Pre-eclampsia can progress within hours, so every antenatal contact includes a BP measurement and a check for danger signs.
Classify
| Finding | Classification | First action |
|---|---|---|
| BP 140/90 or more before 20 weeks | Chronic hypertension | Antenatal follow-up; review her medicines (see below) |
| Two readings 140 to 159 / 90 to 109, four hours apart, after 20 weeks, no proteinuria | Gestational hypertension | Weekly BP, urine and fetal checks |
| As above, with proteinuria (2+ on dipstick) | Pre-eclampsia | Closer monitoring; plan birth with the obstetric team |
| 160/110 or more with proteinuria, or any severe feature: severe headache, blurred vision, upper abdominal pain, breathlessness, vomiting, very little urine | Severe pre-eclampsia | Magnesium sulfate, antihypertensive, urgent referral |
| Convulsions with BP 140/90 or more after 20 weeks, or after birth | Eclampsia | As above; never leave her alone |
The full first-level steps, with doses, are in the protocol Pre-eclampsia and eclampsia. In short: give magnesium sulfate, the medicine of choice to prevent and treat eclamptic fits; if you cannot give the full regimen, give the loading dose and transfer at once. Start an antihypertensive when systolic BP is 160 or more or diastolic 110 or more. Do not lower BP into the normal range quickly.
Medicines in pregnancy
- Stop ACE inhibitors and ARBs as soon as pregnancy is known; they harm the baby. Thiazides and statins are also not used in pregnancy (HEARTS).
- For non-severe hypertension in pregnancy (140 to 159 / 90 to 109), WHO (2020) recommends offering treatment only where the woman has good antenatal follow-up. Methyldopa (fewest safety concerns, on the WHO essential medicines list) and beta-blockers are reasonable choices; the evidence suggests calcium channel blockers should be avoided for this indication. Choose with the antenatal provider.
- For severe hypertension, the acute medicines and doses are in your obstetric protocol and the pre-eclampsia protocol.
- Women who were on antihypertensives in pregnancy should continue them after birth, and severe hypertension after birth should be treated (WHO 2011).
Preventing pre-eclampsia
- Women at high risk (previous pre-eclampsia, chronic hypertension, diabetes, kidney or autoimmune disease, twins): low-dose aspirin 75 mg daily, started before 20 weeks.
- Where dietary calcium is low: calcium 1.5 to 2.0 g a day in pregnancy.
- These belong in routine antenatal care: see The antenatal contact.
A woman with known hypertension who wants a baby
Ask every woman of childbearing age on BP medicines about pregnancy plans and contraception at each review. If she may become pregnant, use a regimen without an ACE inhibitor, ARB or thiazide (lesson 3), and ask her to come as soon as she thinks she is pregnant so that care can be handed to the antenatal team early.
Very high BP outside pregnancy
A very high reading with symptoms (for example BP above 180/110 with headache, chest pain, breathlessness, confusion, weakness or visual loss) needs same-day referral. Without symptoms, 160/100 or more means starting or stepping up treatment the same day, not emergency lowering. Rapid lowering in a clinic can cause a stroke.
Second case: a severe reading at 34 weeks
Ms H, 24, is 34 weeks pregnant with her first baby. She has had a headache since last night and sees flashing lights. BP is 164/112 on two readings 15 minutes apart. Urine protein is 2+.
Severe pre-eclampsia: BP 160/110 or more with proteinuria, and severe features (headache, visual symptoms).
2. What do you do now?
Give magnesium sulfate (the loading dose at least) and an antihypertensive as your protocol shows, do not leave her alone, and arrange urgent transfer to a facility that can deliver the baby, with a written note. Monitor breathing, reflexes and urine output if repeat magnesium doses are given.
Ms G has had hypertension for two years. She takes lisinopril 20 mg and amlodipine 5 mg, and her BP is controlled. She tells you she stopped contraception last month because she wants another child. She is not yet pregnant.
What should change in her treatment now?
Lisinopril (an ACE inhibitor) can harm a baby in early pregnancy, before she knows she is pregnant. Plan with her a regimen without an ACE inhibitor, ARB or thiazide, following your national protocol (HEARTS uses a calcium channel blocker for women who could become pregnant), and check her BP within a month.
Six weeks later she has a positive pregnancy test at 7 weeks. What next?
Confirm she is no longer taking lisinopril, refer her for antenatal care now, and agree her BP treatment with the antenatal provider: WHO names methyldopa and beta-blockers as reasonable options for non-severe hypertension in pregnancy. She is at high risk of pre-eclampsia, so she should be offered low-dose aspirin from before 20 weeks, and calcium where dietary intake is low.
What should she watch for later in pregnancy?
Severe headache, blurred vision, upper abdominal pain, breathlessness, swelling of the face or hands, or fits: come at once, day or night.
- Measure BP at every antenatal contact; 160/110 or more, or any severe feature with raised BP, is severe pre-eclampsia.
- Severe pre-eclampsia: magnesium sulfate (at least the loading dose), an antihypertensive, never alone, urgent referral.
- No ACE inhibitor, ARB, thiazide or statin in pregnancy; methyldopa or a beta-blocker for non-severe hypertension in pregnancy, chosen with the antenatal team.
- Low-dose aspirin before 20 weeks for women at high risk; calcium where intake is low.
- Very high BP with symptoms: same-day referral, not rapid lowering in the clinic.
Quiz and CPD certificate
Answer all 15 questions, then press Mark. You need 12 or more to pass. You can look back at the lessons: the aim is learning. A pass gives a printable certificate of completion for 4 hours of self-directed learning; you need a free account, signed in, to issue it.
Sources
- World Health Organization. Guideline for the pharmacological treatment of hypertension in adults. 2021.
- World Health Organization. HEARTS technical package for cardiovascular disease management in primary health care: evidence-based treatment protocols. 2018 (WHO/NMH/NVI/18.2).
- World Health Organization. HEARTS technical package for cardiovascular disease management in primary health care: risk-based CVD management. 2020.
- World Health Organization. Diagnosis and management of type 2 diabetes (HEARTS-D). 2020 (WHO/UCN/NCD/20.1).
- World Health Organization. Hypertension: fact sheet. 2025.
- World Health Organization. Guideline: sodium intake for adults and children. 2012.
- World Health Organization. HEARTS technical package for cardiovascular disease management in primary health care: systems for monitoring. 2018 (WHO/NMH/NVI/18.5).
- World Health Organization. Hypertension indicators for improving quality and coverage of services: virtual meeting report. 2021 (ISBN 9789240037120).
- World Health Organization. WHO technical specifications for automated non-invasive blood pressure measuring devices with cuff. 2020 (ISBN 9789240002654).
- World Health Organization. WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia. 2011 (ISBN 9789241548335).
- World Health Organization. WHO recommendations on drug treatment for non-severe hypertension in pregnancy. 2020 (ISBN 9789240008793).
- World Health Organization. Managing complications in pregnancy and childbirth: a guide for midwives and doctors, 2nd edition. 2017 (ISBN 9789241565493).
- World Health Organization. WHO recommendations on antenatal care for a positive pregnancy experience. 2016 (ISBN 9789241549912).